Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in France / NCT06705452
Recruiting Not applicable

MRI Analysis in the Growth of Cerebral Aneurysms

NCT06705452 · tracked via the Priya Life Science France tracker
Sponsor
CHU de Reims
Phase
Not applicable
Started
2026-07-08
Last updated
2026-08-07

Condition(s) studied

Unruptured Intracranial Aneurysm

Investigational drug(s) / intervention(s)

Additional 4D Flow MRI or additional 4D Flow sequence

Additional 4D Flow MRI or additional 4D Flow sequence: Additional 4D Flow MRI or additional 4D Flow sequence

Study summary

An intracranial aneurysm is defined as a localized dilatation of the cerebral arteries, which can potentially lead to rupture and subsequent hemorrhagic stroke. The mechanisms by which aneurysms develop and grow remain unknown. The objective of this project is to utilize MRI, a routine non-invasive examination for detecting and following up aneurysms, to identify visually and quantitatively an aneurysm growth and relevant biomarkers that can predict the risk of aneurysm development.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
inclusion criteria: * Patients with one or more unruptured intracranial aneurysms followed up at the participating center. Patients may have other ruptured and/or treated aneurysms * Patient older than 18 years * Patient consenting to participate to the study * Patient enrolled in the national healthcare insurance program exclusion criteria: * Patients who have already received surgical or endovascular treatment for all their aneurysm(s), or who are due to receive such treatment in less than 2 months. * Patients with only ruptured aneurysm(s) * Patients with arteriovenous malformations (treated or untreated) * Patients with a contraindication to MRI * Patients with an allergy to one of the contrast agents (Iodixanol, Gadoteric acid) * Pregnant or breast-feeding patients * Patients protected by law.

Primary outcome measure(s)

  • Evolution of the shape of the aneurysm — At 3 years
    Millimetric quantification of the three-dimensional evolution of the shape of the aneurysm sac, calculated using a computer algorithm

Trial sites (1)

FacilityCityRegionStatus
Damien JOLLY Reims France Recruiting

More CHU de Reims trials in France

Performance of Coronary CT Angiography to Rule Out Coronary Artery Disease After Out-of-hospital Cardiac Arrest Recruiting
Microsurgical Robot-assisted Corneal Transplant Recruiting
Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa Recruiting
Ventilator Associated Pneumonia Multiplex PCR for Anti-Infective Regimens Recruiting
Kynurenine Concentrations During Pregnancy in Women With or Without Chronic Kidney Disease - A Prospective Multicenter Study Starting soon

Other trials for the same condition

Assessment of the Clinical and Economic Impact of Sim&Size, a Simulation Software for Implantable Devices Used in the Treatment of Intracranial Aneurysms: A Prospective Multicenter Study. Recruiting
Patients with Unruptured IntraCranial ANeurysms: Evaluation of the Benefits of Allied Health FollOw-uP in a RandomizEd Controlled Trial Recruiting
Surveillance Versus Treatment of Unruptured Intracranial Aneurysms of Fortuitous Discovery Starting soon
Unruptured Cerebral Aneurysm: Prediction of Evolution Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06705452 on ClinicalTrials.gov ↗ ← All trials in France